Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy.
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Phosphomannose isomerase (PMI) deficiency is the cause of a new type of carbohydrate-deficient glycoprotein syndrome (CDGS). The disorder is caused by mutations in the PMI1 gene. The clinical phenotype is characterized by protein-losing enteropathy, while neurological manifestations prevailing in other types of CDGS are absent. Using standard diagnostic procedures, the disorder is indistinguishable from CDGS type Ia (phosphomannomutase deficiency). Daily oral mannose administration is a successful therapy for this new type of CDG syndrome classified as CDGS type Ib.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphomannomutase deficiency is a cause of carbohydrate‐deficient glycoprotein syndrome type I
(1995) · FEBS Letters · doi:10.1016/0014-5793(95)01357-1 · Cited by 359 · cited 6×
“ing to a procedure by van Schaftingen and Jaeken (6).”
BackgroundMethodInfluentialJaeken, J., Vanderschueren-Lodeweyckx, M., Casaer, P., Snoeck, L., Corbeel, L., Eggermont, E., & Eeckels, R. (1980) · Pediatric Research · doi:10.1203/00006450-198002000-00117 · Cited by 287 · cited 1×
“(1) Hexokinase; (2) glucose 6-phosphate dehydrogenase; (3) phosphoglucose isomerase; (4) phosphomannose isomerase; (5) phosphomannomutase; (6) GDPmannose synthase.”
Panneerselvam, K., & Freeze, H. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118570 · Cited by 146 · cited 1×
“Based on studies showing that mannose could correct abnormal glycosylation in CDGS type Ia fibroblasts (15), mannose therapy was initiated and followed up for 11 mo.”
BackgroundSelf-citationThe X-ray crystal structure of phosphomannose isomerase from Candida albicans at 1.7 Å resolution
Cleasby, A., Wonacott, A. J., Skarzynski, T. J., Hubbard, R. E., Davies, G. J., Proudfoot, A. E. I., Bernard, A. R., Payton, M. A., & Wells, T. N. C. (1996) · Nature Structural Biology · doi:10.1038/nsb0596-470 · Cited by 115
Alton, G., Kjærgaard, S., Etchison, J. R., Skovby, F., & Freeze, H. H. (1997) · Biochemical and Molecular Medicine · doi:10.1006/bmme.1997.2574 · Cited by 111 · cited 1×
“In accordance with previous human ingestion studies (19), mannose was given orally in an initial dose of 100 mg/kg body wt three times a day.”
Self-citationCarbohydrate-Deficient Glycoprotein Syndrome - A Fourth Subtype
Stibler, H., Stephani, U., & Kutsch, U. (1995) · Neuropediatrics · doi:10.1055/s-2007-979762 · Cited by 92 · cited 1×
“(1) Hexokinase; (2) glucose 6-phosphate dehydrogenase; (3) phosphoglucose isomerase; (4) phosphomannose isomerase; (5) phosphomannomutase; (6) GDPmannose synthase.”
Purification cDNA cloning and heterologous expression of human phosphomannose isomerase
PROUDFOOT, A. E. I., TURCATTI, G., WELLS, T. N. C., PAYTON, M. A., & SMITH, D. J. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb19954.x · Cited by 86 · cited 3×
“The sequence of the human PMI cDNA (10) was used to design primers for PCR amplification.”
BackgroundMethodInfluentialCarbohydrate-Deficient Glycoprotein (CDG) Syndrome - A New Variant, Type III
Stibler, H., Westerberg, B., Hanefeld, F. A., & Hagberg, B. (1993) · Neuropediatrics · doi:10.1055/s-2008-1071513 · Cited by 71 · cited 1×
“(1) Hexokinase; (2) glucose 6-phosphate dehydrogenase; (3) phosphoglucose isomerase; (4) phosphomannose isomerase; (5) phosphomannomutase; (6) GDPmannose synthase.”
Human Fibroblasts Prefer Mannose over Glucose as a Source of Mannose for N-Glycosylation
Panneerselvam, K., Etchison, J. R., & Freeze, H. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.37.23123 · Cited by 70
Self-citationA novel Saccharomyces cerevisiae secretory mutant possesses a thermolabile phosphomannose isomerase
Payton, M. A., Rheinnecker, M., Klig, L. S., Detiani, M., & Bowden, E. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.6.2006-2010.1991 · Cited by 70 · cited 1×
“Phenotypic correction of the PMI deficiency in yeast was achieved by supplying 5 mM mannose together with glucose (20).”
MethodPowell, L. D., Paneerselvam, K., Vij, R., Diaz, S., Manzi, A., Buist, N., Freeze, H., & Varki, A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117540 · Cited by 69
Self-citationEnzymatic assay of d-mannose in serum
Etchison, J. R., & Freeze, H. H. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.3.533 · Cited by 60 · cited 8×
“Further clinical details will be described elsewhere (Harms, H.K., K. Reiter, K.-P. Zimmer, K. Auberger, R.M. Bertele-Harms, S. Weidinger, H. Freeze, L. Niehues, M. Hasilik and T. Marquardt, manuscript in preparation).”
BackgroundMethodInfluentialSelf-citationKrasnewich, D. M., Holt, G. D., Brantly, M., Skovby, F., Redwine, J., & Gahl, W. A. (1995) · Glycobiology · doi:10.1093/glycob/5.5.503 · Cited by 53
la Fuente, M. D., Fernández‐Peñas, P., & Sols, A. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)91056-9 · Cited by 50 · cited 1×
“However, this so-called “honeybee syndrome” (21) has no relevance for the oral mannose therapy in PMI-deficient patients, since the uptake capacity of the gut is a natural protection.”
BackgroundStibler, H., Holzbach, U., Tengborn, L., & KRISTIANSSON, B. (1996) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199603000-00003 · Cited by 50 · cited 1×
“Low AT III levels initiated CDGS diagnostics (11).”
BackgroundKorner, C., Lehle, L., & von Figura, K. (1998) · Glycobiology · doi:10.1093/glycob/8.2.165 · Cited by 48 · cited 1×
“olites was determined as described earlier (17).”
Self-citationCarbohydrate‐deficient glycoprotein syndrome type II
Jaeken, J., Cock, P. D., Stibler, H., Geet, C. V., Kint, J. A., Ramaekers, V. T., & Carchon, H. A. (1993) · Journal of Inherited Metabolic Disease · doi:10.1007/bf00711522 · Cited by 40
Wells, T. N. C., Coulin, F., Payton, M. A., & Proudfoot, A. E. I. (1993) · Biochemistry · doi:10.1021/bi00056a014 · Cited by 37
Enzymes of mannose metabolism in murine and human lymphocytic leukaemia
la Fuente, M. D., & Hernánz, Á. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.260 · Cited by 15 · cited 1×
“The peak mannose concentrations in the patient’s serum were 60-fold lower than the toxic dose in PMI-deficient tumor cells (22).”
BackgroundZimmer, K.-P., Matsuda, I., Matsuura, T., Mori, M., Colombo, J. P., Fahimi, H. D., Koch, H. G., Ullrich, K., & Harms, E. (1995) · PubMed · Cited by 15
Self-citation
Cited by
Glycosylation in Cellular Mechanisms of Health and Disease
Ohtsubo, K., & Marth, J. D. (2006) · Cell · doi:10.1016/j.cell.2006.08.019 · Cited by 2,788
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
A Genetic Approach to Mammalian Glycan Function
Lowe, J. B., & Marth, J. D. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161809 · Cited by 594
Genetic defects in the human glycome
Freeze, H. H. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1894 · Cited by 467
“cgi?id=602579">CDG-Ib , which is caused by mutations in phosphomannose isomerase ( MPI ) have a milder phenotype than those with CDG-Ia, without developmental delay or psychomotor retardation, and respond to dietary therap”
BackgroundSelf-citationLehle, L., Strahl, S., & Tanner, W. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200601645 · Cited by 316
Metadata
- Authors
- Niehues, R., Hasilik, M., Alton, G., Körner, C., Schiebe-Sukumar, M., Koch, H. G., Zimmer, K. P., Wu, R., Harms, E., Reiter, K., von Figura, K., Freeze, H. H., Harms, H. K., & Marquardt, T.
- Affiliations
- University Hospital Münster (DE)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- University of Göttingen (DE)
- Venue
- Journal of Clinical Investigation
- Published
- 1998-04-01
- Volume
- 101
- Issue
- 7
- Pages
- 1414-1420
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC508719
- OpenAlex
- W1970122244
- Cited by
- 422
- References
- 20
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 13 · 2023: 11 · 2022: 8 · 2021: 14 · 2020: 16 · 2019: 7 · 2018: 12 · 2017: 12 · 2016: 4 · 2015: 13 · 2014: 18 · 2013: 7 · 2012: 14
- FWCI
- 22.32
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01gm049096-04)
- National Institute of General Medical Sciences (R01 GM49096)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- protein-losing enteropathy, phosphomannomutase deficiency
- MeSH terms
- Cells, Cultured, Glycoproteins, Glycosylation, Humans, Infant, Male, Mannose, Mannose-6-Phosphate Isomerase, Mutation, Protein Processing, Post-Translational, Protein-Losing Enteropathies, Syndrome, Transferrin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.